Bruce R A, Hossack H F, Kusumi F, Clarke L J
Am J Cardiol. 1979 Jul;44(1):132-40. doi: 10.1016/0002-9149(79)90262-5.
Noninvasive measurements of maximal oxygen intake and invasive measurement of systemic and pulmonary arterial pressures, arterial and mixed venous oxygen contents and direct Fick cardiac output are reported for 3 healthy men and 14 men with coronary heart disease. Observations were obtained at supine and sitting rest, during graded levels of upright exercise on a treadmill up to symptom-limited maximal effort and in two periods of recovery. The effects of 40 mg of propranolol orally were ascertained by repeating the measurements 1 to 1 1/2 hours later. The most consistent effect of propranolol was reduction of pressure-rate products at all phases; slowing of heart rate was significant only during exercise and recovery, and the greater slowing was accompanied by a significant increase in stroke volume. These changes were similar in patients with and without evidence of left ventricular impairment greater than 15 percent on exercise testing. Maximal oxygen intake decreased in healthy subjects and decreased slightly in patients with coronary heart disease with less than 15 percent left ventricular impairment or percent deviation of pressure-rate product from age-predicted normal values during the control study. Maximal oxygen intake increased in patients with more than 15 percent left ventricular impairment. Arterial-mixed venous oxygen difference increased after propranolol because of a reduction of mixed-venous oxygen content attributed to greater peripheral extraction of oxygen.
报告了3名健康男性和14名冠心病男性的最大摄氧量无创测量以及体循环和肺动脉压、动脉血和混合静脉血氧含量的有创测量及直接Fick心输出量。观察在仰卧位和坐位休息时、在跑步机上进行分级直立运动直至症状限制的最大努力期间以及两个恢复阶段进行。1至1个半小时后重复测量,以确定口服40毫克普萘洛尔的效果。普萘洛尔最一致的效果是在所有阶段降低压力-心率乘积;心率减慢仅在运动和恢复期间显著,且较大程度的减慢伴随着每搏量的显著增加。在运动试验中左心室功能损害大于15%和无此证据的患者中,这些变化相似。在对照研究期间,健康受试者的最大摄氧量降低,左心室功能损害小于15%或压力-心率乘积与年龄预测正常值偏差百分比的冠心病患者的最大摄氧量略有降低。左心室功能损害大于15%的患者最大摄氧量增加。普萘洛尔治疗后,由于混合静脉血氧含量降低(归因于外周对氧的摄取增加),动脉-混合静脉血氧差增大。